Status:
ENROLLING_BY_INVITATION
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
Lead Sponsor:
Cleerly, Inc.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.
Detailed Description
CONFIRM2 is a retrospective and prospective, open-label, international, multicenter observational registry designed to evaluate associations between CCTA imaging findings and clinical presentation (cr...
Eligibility Criteria
Inclusion
- Age \>18 years
- Undergoing clinically indicated CCTA with \>64-detector row CT
- Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation
Exclusion
- Individuals unable to provide informed consent
- Non-cardiac illness with life expectancy \< 2 years
- Pregnancy
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
35000 Patients enrolled
Trial Details
Trial ID
NCT04279496
Start Date
June 1 2020
End Date
June 1 2027
Last Update
November 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia
Charlottesville, Virginia, United States, 22904